Benzofused Macrocyclic Lactams as Triple Inhibitors of Endothelin-Converting Enzyme, Neutral Endopeptidase 24.11, and Angiotensin-Converting Enzyme
- 1 January 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 31, S71-S73
- https://doi.org/10.1097/00005344-199800001-00023
Abstract
The purpose of this study was to identify endothelin-converting enzyme (ECE) inhibitors that also possess inhibitory activity for neutral endopeptidase 24.11 (NEP) and angiotensin-converting enzyme (ACE). The ortho-substituted benzofused macrocyclic lactams, such as CGS 26670, are generally potent NEP inhibitors but poor ACE inhibitors. CGS 26670 inhibited ECE activity with an IC50 of 600 nM, whereas it inhibited NEP and ACE activities with IC50 values of 0.9 and >10,000 nM, respectively. This compound also prevented the conversion of big endothelin-1 (big ET-1) to ET-1 by denuded porcine coronary arterial smooth muscle with an IC50 of 200 nM. The ACE inhibitory activity is greatly improved in metasubstituted benzofused macrocyclic lactams. For example, CGS 26582 inhibited ECE, NEP, and ACE activities with IC50 values of 620, 4, and 175 nM, respectively. When injected at 30 mg/kg i.v. in conscious rats, followed by a challenge with big ET-1 at 1 nmol/kg i.v., this compound suppressed by 44% the increase in mean arterial blood pressure owing to the generation of ET-1 by ECE. Because ECE, NEP, and ACE play regulatory roles in cardiovascular and renal function, triple inhibitors of these enzymes may represent a novel class of agents for treatment of cardiovascular and renal diseases.Keywords
This publication has 6 references indexed in Scilit:
- Ortho-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease InhibitorsJournal of Medicinal Chemistry, 1997
- Meta-Substituted Benzofused Macrocyclic Lactams as Zinc Metalloprotease InhibitorsJournal of Medicinal Chemistry, 1997
- Design and Pharmacology of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase InhibitorsCurrent Pharmaceutical Design, 1996
- Molecular pharmacology of endothelin converting enzymesBiochemical Pharmacology, 1996
- Effect of immunoglobulin light chains from hemodialysis and continuous ambulatory peritoneal dialysis patients on polymorphonuclear leukocyte functions.Journal of the American Society of Nephrology, 1995
- Effects of metalloprotease inhibitors on smooth muscle endothelindashconverting enzyme activityBiochemical Pharmacology, 1995